Book of abstracts - British Neuroscience Association
Book of abstracts - British Neuroscience Association
Book of abstracts - British Neuroscience Association
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
9.08<br />
Regulation <strong>of</strong> potassium channel genes in response to neuronal<br />
activity<br />
Mucha M, Mordaka P M, Dalle C, Wood I C<br />
Institute <strong>of</strong> Membrane and Systems Biology, University <strong>of</strong> Leeds,<br />
Leeds LS2 9JT, UK<br />
Epilepsy is the second most common neurological disease and 1 in 20<br />
individuals will suffer an epileptic event sometime during their lifetime.<br />
Once a seizure has occurred an individual becomes more susceptible<br />
to further seizures. Although it is known that this effect requires<br />
changes in gene expression, the exact nature <strong>of</strong> those changes is not<br />
understood. It is likely that changes in expression <strong>of</strong> genes that<br />
regulate neuronal excitability would be important for this response to<br />
seizure activity. To investigate how such genes are regulated we have<br />
isolated the genes, KCNQ2 and KCNQ3, which encode two potassium<br />
channel subunits <strong>of</strong> the M-channel and function to regulate neuronal<br />
excitability. Mutations in either KCNQ2 or KCNQ3, resulting in<br />
diminished function in humans are responsible for a form <strong>of</strong> epilepsy<br />
indicating the important role <strong>of</strong> these subunits. We have used<br />
bioinformatic analysis, DNase I sensitivity, gel retardation assays and<br />
reporter gene assays to identify functional promoter elements within<br />
the human KCNQ2 and KCNQ3 genes. We show that KCNQ2 and<br />
KCNQ3 are regulated by at least some shared transcription factors<br />
that respond to seizure activity and that expression levels <strong>of</strong> these<br />
genes in cultured neurons are responsive to neuronal activity.<br />
9.09<br />
The phosphorylation status <strong>of</strong> the p65 NF-kB subunit determines<br />
whether NF-kB promotes or inhibits neurite growth<br />
Gutierrez H, O`Keefe G, Davies A<br />
Humberto Gutierrez PhD , Research Associate., Cardiff School <strong>of</strong><br />
Biosciences,, Biomedical Sciences Building 3,, Museum Avenue,, PO Box<br />
911,, Cardiff CF10 3US,, Wales, UK, e-mail:gutierrezh@cf.ac.uk, Tel:<br />
+(44)29 20 87 51 76<br />
NF-kB is a ubiquitously expressed transcription factor that has recently<br />
been shown to promote the growth <strong>of</strong> neural processes in the developing<br />
peripheral and central nervous systems. The NF-kB dimer is held in an<br />
inactive form in the cytoplasm by a member <strong>of</strong> the IkB family <strong>of</strong> inhibitory<br />
proteins, and NF-kB is normally activated by IkB kinase<br />
(IKK)-mediated phosphorylation <strong>of</strong> IkB on serine residues 32 and 36,<br />
resulting in ubiquitination and proteosome-mediated degradation <strong>of</strong> IkB and<br />
nuclear translocation <strong>of</strong> the liberated NF-kB. Overexpressing the<br />
common p65/p50 NF-kB dimer in nodose ganglion sensory neurons<br />
cultured from newborn mice enhanced NF-kB transcriptional activity and<br />
increased neurite growth. Paradoxically, overexpressing IKK2 (but not<br />
IKK1) also<br />
enhanced NF-kB transcriptional activity but strongly inhibited neurite<br />
growth. Furthermore, both p65/p50 growth stimulation and IKK2 growth<br />
inhibition were reversed by expressing an IkBa mutant that cannot be<br />
phosphorylated on serine residues. In addition to phosphorylating IkBa,<br />
IKK2 (but not IKK1) phosphorylated p65 on serine 536 in these neurons.<br />
Overexpression <strong>of</strong> a p65 mutant (S536A) that cannot be phosphorylated at<br />
this site restored growth in IKK2 overexpressing neurons. Overexpression<br />
<strong>of</strong> a phosphomimetic p65 mutant (S536D) led to a strong inhibition <strong>of</strong><br />
neurite growth. Taken together these results suggest that NF-kB can both<br />
stimulate and inhibit neurite growth depending on the phosphorylation<br />
status <strong>of</strong> p65. The implications for other neural populations and<br />
extracellular signals involving NFkB activation are discussed<br />
9.10<br />
A novel TNF-alpha autocrine loop activates the canonical NF-kB<br />
pathway to limit NGF-promoted axonal growth in developing<br />
neurons.<br />
O’Keeffe G W, Gutierrez H, Gavalda N, Davies A M<br />
Cardiff School <strong>of</strong> Biosciences, Museum Avenue, Cardiff CF10 3US,<br />
Wales.<br />
Multiple signals from various cells control the growth, guidance and<br />
terminal sprouting <strong>of</strong> axons in the developing nervous system as they<br />
grow towards and within their innervation targets. Here we report a<br />
novel autocrine signalling loop involving TNF-alpha produced by the<br />
neurons themselves. This autcrine signalling loop functions to<br />
regulate NGF-dependant axonal growth during the postnatal<br />
development <strong>of</strong> mouse sympathetic neurons.<br />
We found that TNF-alpha, signalling through TNFR1 significantly<br />
reduced NGF-dependant neurite growth in sympathetic neurons<br />
during a "developmental window". In these neurons, TNF-alpha<br />
activated NF-kB as measured by degradation and Ser32/36<br />
phosphorylation <strong>of</strong> IkB-alpha and an increase in NF-kB dependant<br />
gene transcription using a GFP-reporter NF-kB construct. Using<br />
selective mutants <strong>of</strong> proteins involved in the canonical and noncanonical<br />
NF-kB signalling pathways, we found that that selectively<br />
inhibiting NF-kB activation through the canonical pathway prevented<br />
the reduction in growth triggered by TNF-alpha in sympathetic<br />
neurons.<br />
These results describe a novel function and mechanism <strong>of</strong> action for<br />
TNF-alpha during neuronal development and they reveal a<br />
unsuspected autocrine signalling loop in developing neurons that acts<br />
to limit the extent <strong>of</strong> NGF-dependent axonal growth.<br />
10.01<br />
Interleukin-1 exacerbates excitotoxic brain injury via a neutrophil<br />
dependant mechanism<br />
LM McCluskey, SM Allan<br />
Faculty <strong>of</strong> Life Sciences, University <strong>of</strong> Manchester, UK<br />
Interleukin-1 (IL-1) is a pro-inflammatory cytokine that exacerbates<br />
neurodegeneration, including alpha-amino-3-hydroxy-5-methyl-4-<br />
isoxazolepropionate (AMPA) induced excitotoxic neuronal death. The aim <strong>of</strong><br />
this study was to test the hypothesis that neutrophils contribute to IL-1<br />
mediated exacerbation <strong>of</strong> injury.<br />
Male Sprague-Dawley rats were injected in the striatum with vehicle, AMPA,<br />
IL-1 or AMPA plus IL-1 (A+IL-1), sacrificed 4 or 8h post-injection and serum,<br />
brain and liver removed. Immunohistochemistry was performed to<br />
investigate neutrophil recruitment and c-fos expression. Serum, brain and<br />
liver cytokine-induced neutrophil chemo-attractant-1 (CINC-1) levels were<br />
determined by ELISA. A separate cohort was pre-treated with neutrophil<br />
depletion serum or normal rabbit serum (control) before intra-striatal<br />
injection <strong>of</strong> A+IL-1. The animals were killed 24h later and whole blood and<br />
brain removed. Brain lesion volume was calculated from cresyl-violet<br />
stained sections. Immunohistochemistry was used to detect neutrophils<br />
within the brain and circulating neutrophils were counted in the blood.<br />
Injection <strong>of</strong> AMPA+IL-1 caused extensive neutrophil recruitment and c-fos<br />
expression at 4 and 8h compared to injection <strong>of</strong> vehicle, AMPA or IL-1.<br />
CINC-1 levels in the serum, brain and liver were induced to a similar extent<br />
at 4h by IL-1 or A+IL-1, but not by vehicle or AMPA. Serum and brain CINC-<br />
1 levels declined between 4 and 8h after IL-1 treatment, but remained<br />
elevated at 8h after A+IL-1 treatment. Neutrophil depletion <strong>of</strong> animals prior<br />
to injection <strong>of</strong> A+IL-1 reduced the resulting total lesion volume by 60%<br />
compared to control.<br />
These data suggest that IL-1 exacerbates excitotoxic brain injury by a<br />
neutrophil dependant mechanism, possibly via CINC-1.<br />
Page 16/101 - 10/05/2013 - 11:11:03